Prodotto aggiunto correttamente al carrello.

(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
Visualizzare in 3D

Indagoo logo

(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid

CAS: 745-65-3

Rif. AN-AG0038GD

1g
Fuori produzione
5mg
Fuori produzione
10mg
Fuori produzione
25mg
Fuori produzione
50mg
Fuori produzione
100mg
Fuori produzione
250mg
Fuori produzione

Prodotto fuori produzione. Per informazioni su prodotti simili, compilare il nostro modulo di richiesta o inviarci un'e-mail a .


Informazioni sul prodotto

Nome:
(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
Sinonimi:
  • [u'Alprostadil', u'Caverject', u'Edex', u'Lipo PGE1', u'Lipo-PGE1', u'Minprog', u'Muse', u'PGE1', u'PGE1alpha', u'Prostaglandin E1', u'Prostaglandin E1alpha', u'Prostavasin', u'Prostin VR', u'Prostine VR', u'Sugiran', u'Vasaprostan', u'Viridal', u'alprostadil', u'Prostaglandin E1', u'745-65-3', u'PGE1', u'Caverject', u'Edex', u'Muse', u'Prostin VR', u'Alprostadilum', u'Femprox', u'Befar', u'Liprostin', u'Prostandin', u'Vitaros', u'PGE-1', u'Befar (TN)', u'Prink (TN)', u'Prostavasin', u'Topiglan', u'Vasaprostan', u'Alprostadil(Caverject)', u'Alprox-TD', u'Prostaglandin-E1', u'l-Prostaglandin E1', u'MR-256', u'Minprog', u'UNII-F5TD010360', u'(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid', u'CHEMBL495', u'Prostin VR Pediatric', u'Lipoprost', u'Prostivas', u'Alista', u'Prink', u'11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid', u'(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate', u'CHEBI:15544', u'PGE1alpha', u'9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid', u'GMVPRGQOIOIIMI-DWKJAMRDSA-N', u'U-10136', u'7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid', u'F5TD010360', u'(-)-Protaglandin E1', u'Sugiran', u'Viridal', u'(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid', u'l-PGE1', u'Alprostadilum [INN-Latin]', u'PGE1 Oligomer', u'7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid', u'Alprostadil Prostoglandin E1', u'Promostan', u'FemLife', u'ONO 1608', u'EINECS 212-017-2', u'RayVa', u'Prostaglandine E', u'Caverject Impulse', u'NSC 165559', u'7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', u'7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid', u'CPD000112594', u'SMR000112594', u'AI3-62116', u'U 10136', u'SR-01000597593', u'MR 256', u'Prostin VR pediatric (TN)', u'BML1-F06', u'3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-', u'Alprostadil(usan)', u'HEI-507', u'(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'NCGC00016535-01', u'119314-69-1', u'CAS-745-65-3', u'Vitaros (TN)', u'(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate', u'Alprostadil [USAN:USP:INN:BAN:JAN]', u'AC1NQXHQ', u'11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid', u'PGE1;Prostaglandin E1', u'Prestwick2_001018', u'Prestwick3_001018', u'U-10,136', u'DSSTox_CID_2578', u'Prostaglandin E1, 98+%', u'DSSTox_RID_76640', u'DSSTox_GSID_22578', u'SCHEMBL33317', u'BSPBio_001175', u'BSPBio_001488', u'MLS000758964', u'MLS001424250', u'BIDD:GT0747', u'BPBio1_001293', u'GTPL1882', u'Alprostadil (JP17/USP/INN)', u'Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-', u'DTXSID9022578', u'PGE1, Prostaglandin E1, powder', u'SYN3025', u'HMS1361K10', u'HMS1571K17', u'HMS1791K10', u'HMS1989K10', u'HMS2052L11', u'HMS2090L08', u'HMS2098K17', u'HMS3268I09', u'HMS3402K10', u'HMS3648O17', u'HMS3678N07', u'HMS3715K17', u'(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid', u'BCP01740', u'EX-A1411', u'HY-B0131', u'ZINC3813088', u'Tox21_110482']
  • (-)-Prostaglandin E<sub>1</sub>
  • (11alpha,12xi,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
  • (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oate
  • (11alpha,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
  • 11,15-Dihydroxy-9-Oxoprost-13-En-1-Oic Acid
  • 11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid
  • 11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid
  • Aiprostadil
  • Alprostadil
  • Vedi altri sinonimi
  • Alprostan
  • Alprox TD
  • Caveject
  • Caverject
  • Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-
  • Cyclopentaneheptanoic acid, 3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-
  • Eglandin
  • Liple
  • Lipo PGE1
  • Lipoprost
  • Liprostin
  • Minprog
  • Nsc 165559
  • Ono 1608
  • PGE<sub>1</sub>
  • Palux
  • Pge1
  • Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-
  • Prostandin
  • Prostandin 500
  • Prostin VR Pediatric
  • Prostivas
  • SEPA-alprostadil
  • SEPA-prostaglandin E1
  • Sepa-Pge1
  • Topiglan
  • U 10136
  • Vasaprostan
  • l-PGE1
  • l-PGE<sub>1</sub>
  • l-Prostaglandin E1
  • l-Prostaglandin E<sub>1</sub>
  • prostandin E1
Marchio:
Indagoo
Conservazione lunga:
Note:

Proprietà chimiche

Peso molecolare:
354.4810
Formula:
C20H34O5
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1
InChI key:
GMVPRGQOIOIIMI-DWKJAMRDSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta di informazioni sul prodotto fuori produzione: AN-AG0038GD (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".